Gene of the month: BAP1
Authors:
- 27 May 2016
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 69 (9) , 750-753
Abstract
The BAP1 gene (BRCA1-associated protein 1) is a tumour suppressor gene that encodes a deubiquitinating enzyme (DUB), regulating key cellular pathways, including cell cycle, cellular differentiation, transcription and DNA damage response. Germline BAP1 mutations cause a novel cancer syndrome characterised by early onset of multiple atypical Spitz tumours and increased risk of uveal and cutaneous melanoma, mesothelioma, renal cell carcinoma and various other malignancies. Recognising the clinicopathological features of specific BAP1-deficient tumours is crucial for early screening/tumour detection, with significant impact on patient outcome.Keywords
This publication has 36 references indexed in Scilit:
- Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivationScientific Reports, 2015
- The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in CancerJournal of Biological Chemistry, 2015
- BRCA1-associated Protein 1 (BAP1) Deubiquitinase Antagonizes the Ubiquitin-mediated Activation of FoxK2 Target GenesJournal of Biological Chemistry, 2015
- The potential role of O-GlcNAc modification in cancer epigeneticsCellular & Molecular Biology Letters, 2014
- BAP1 and cancerNature Reviews Cancer, 2013
- Tumours associated with BAP1 mutationsPathology, 2013
- Emerging Anatomy of the BAP1 Tumor Suppressor SystemScience, 2012
- The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene ExpressionMolecular and Cellular Biology, 2010
- Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1Molecular and Cellular Biology, 2009
- BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear LocalizationCancer Research, 2008